Regencell's stock soared 17,000% fueled by speculation, despite no revenue or clinical progress. Read why I think the RGC ...

Fortress Biotech, Inc. (Nasdaq: FBIO) ("Fortress"), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value ...

The rise of VRE through the 1990s focused our attention on how natural product ... as development candidates. Figure 1 is a variant of a typical drug discovery/development flow chart adapted ...

Alexandria Real Estate offers an unusually high 7.5% yield, at multi-decade low valuations. Click to read why ARE is rated ...

This review highlights the high performance liquid chromatography (HPLC), mass spectrometry (MS), chromatography data systems ...

Shares of CRISPR Therapeutics CRSP have risen 14% over the past month, likely driven by encouraging results from the first ...

Behind A/B testing lies a strategic approach that is reshaping how modern products are designed, refined and launched.

development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA (MDXX class molecules), has become aware of unknown parties illegally retailing a nasal spray online, falsely claiming to be ...

A dual-track approach has gained momentum for biotech companies as capital markets remain volatile and acquirers become more ...

With finite natural resources and a growing demand for food, the world must find ways to overcome this challenge. One ...

PharmAla’s LaNeo MDMA drug products are ... PharmAla Biotech Holdings Inc. (CSE: MDMA) (OTCQB: MDXXF) is a biotechnology company focused on the research, development, and manufacturing of ...